Ifm Investors Pty LTD 10x Genomics, Inc. Transaction History

Ifm Investors Pty LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$36.95 - $82.41 $426,735 - $951,753	-11,549 Closed	0 $0
Q1 2022 Apr 13, 2022	BUY	$55.7 - $145.79 $106,888 - $279,771	1,919 Added 19.93%	11,549 $879,000
Q4 2021 Jan 18, 2022	BUY	$135.05 - $182.59 $52,264 - $70,662	387 Added 4.19%	9,630 $1.43 Million
Q3 2021 Oct 13, 2021	SELL	$145.58 - $192.14 $20,526 - $27,091	-141 Reduced 1.5%	9,243 $1.35 Million
Q2 2021 Jul 16, 2021	BUY	$134.22 - $202.37 $347,495 - $523,935	2,589 Added 38.1%	9,384 $1.84 Million
Q1 2021 May 05, 2021	BUY	$140.25 - $196.86 $60,868 - $85,437	434 Added 6.82%	6,795 $1.23 Million
Q4 2020 Jan 13, 2021	BUY	$126.47 - $163.7 $804,475 - $1.04 Million	6,361 New	6,361 $901,000

287

94.9M

162K

107K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.54B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Ifm Investors Pty LTD with notifications on news.